Wendan decoction for dyslipidemia: Protocol for a systematic review and meta-analysis

BACKGROUND: Dyslipidemia is one of the most popular metabolic diseases and an important risk factor for arteriosclerotic cardiovascular diseases. In China, Wendan decoction (WDD) has been widely used to treat hyperlipidemia. However, no systematic review has been found. In order to evaluate the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wenwei, Ye, Xiaohan, Lv, Hongxue, Hou, Chijun, Chen, Yingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370125/
https://www.ncbi.nlm.nih.gov/pubmed/30653157
http://dx.doi.org/10.1097/MD.0000000000014159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370125/
https://www.ncbi.nlm.nih.gov/pubmed/30653157
http://dx.doi.org/10.1097/MD.0000000000014159

Ejemplares similares